SCHEMBL7075766

SCHEMBL7075766

NC(=O)COc1ccc2c(c1)S(=O)(=O)N=C(c1c(O)c3cccnc3n(CCC3CC3)c1=O)N2

nearest known ligand 0.73

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 3/20 0.73
NR1I2 O75469 1/20 0.52
MAPK1 P28482 1/20 0.39
HSD17B10 Q99714 1/20 0.39
CNR2 P34972 7/20 0.34
CNR1 P21554 5/20 0.34
HTR3E A5X5Y0 1/20 0.34
HTR3B O95264 1/20 0.34
HTR3A P46098 1/20 0.34
HTR3D Q70Z44 1/20 0.34
HTR3C Q8WXA8 1/20 0.34
ADORA2A P29274 1/20 0.32
ADORA2B P29275 1/20 0.32
ADORA1 P30542 1/20 0.32
HIF1A Q16665 1/20 0.31
PIK3CA P42336 1/20 0.31
DPP4 P27487 1/20 0.31
MGAT2 Q10469 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6684550 0.90 CYP2C9 (0.82) CYP2C9NR1I2MAPK1HSD17B10ADORA2A
SCHEMBL7130420 0.89 CYP2C9 (0.73) CYP2C9NR1I2MAPK1HSD17B10CNR2
SCHEMBL7130416 0.89 CYP2C9 (0.73) CYP2C9NR1I2MAPK1HSD17B10CNR2
SCHEMBL6267035 0.88 CYP2C9 (0.90) CYP2C9NR1I2MAPK1HSD17B10CNR2
SCHEMBL1522705 0.87 CYP2C9 (0.56) CYP2C9NR1I2MAPK1HSD17B10DPP4
SCHEMBL6736116 0.85 CYP2C9 (0.84) CYP2C9NR1I2MAPK1HSD17B10CNR2
SCHEMBL6234512 0.85 CYP2C9 (1.00) CYP2C9NR1I2MAPK1HSD17B10HIF1A
SCHEMBL6692151 0.81 CYP2C9 (0.67) CYP2C9NR1I2MAPK1HSD17B10HIF1A
SCHEMBL1523427 0.81 CYP2C9 (0.48) CYP2C9NR1I2MAPK1HSD17B10HTR3E
SCHEMBL1522413 0.81 CYP2C9 (0.62) CYP2C9NR1I2MAPK1HSD17B10CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003059356-A2 NOVEL ANTI-INFECTIVES SMITHKLINE BEECHAM CORPORATION (US) 2003-07-24 WO disclosed